SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (the “Company”; NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it filed its Annual Report on Form 20-F for the year ended December 31, 2007 with the Securities and Exchange Commission on June 30, 2008. The Annual Report on Form 20-F can be accessed via the investor relations section of the Company’s website at http://www.tongjitang.com.
